The Oraya Therapy is now available in Guildford and Manchester, United Kingdom, Basel, Switzerland and Lübeck, Germany, with additional locations coming soon. For more information, call 0800-690-6495 in the United Kingdom and in Germany call 0800-283-2243.
For a limited time and while supplies last, Oraya is offering interested physicians a free copy of the article, Stereotactic low voltage x-ray radiotherapy for treating neovascular age-related macular degeneration, published in Expert Review of Ophthalmology, 2014. Download >
For a limited time and while supplies last, Oraya is offering interested physicians a free copy of the INTREPID Study Results published in Ophthalmology, September 2013. Download >
Oraya Therapeutics named to San Francisco Business Times I-List – the 40-most innovative life science companies in the Bay Area. More >
Age-Related Macular Degeneration (AMD) is a progressive disease that causes loss of central vision leading to blindness. It is the primary cause of vision loss for seniors in the industrialized world. While there is no cure for AMD, the Oraya Therapy™ for Wet AMD is an exciting new treatment. More >
Founded in 2007, Oraya® Therapeutics, Inc. is a privately held company developing an innovative and non-invasive therapy designed to advance the treatment options for wet AMD. More >
Physicians and patients require a new option and a new vision for the treatment of wet AMD. Oraya Therapy— intended as a one-time, non-invasive procedure—uses a low-voltage, stereotactic approach. It delivers precisely controlled X-rays confined to the diseased area of interest, sparing the surrounding structures of the eye. More >